1-20 of 129
Pierluigi Porcu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Zanubrutinib and Ibrutinib As Treatments for Waldenstrom Macroglobulinemia: A Real-World Retrospective Study

Francesco Iadevaia, Ramsay Hafer, Thomas Z Rohan, Alan Khoo, Luca Laurenti, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 5111.
https://doi.org/10.1182/blood-2024-208987
Published: 2024
Journal Articles

The Risk of Developing Non-Melanoma Skin Cancers in Patients with Cutaneous T-Cell Lymphoma

Ramsay Hafer, Teresa Duong, Jenna Mandel, Henry Y Yang, Julianna Tolotta, Lauren Banner, Safiyyah Bhatti, Pierluigi Porcu, Neda Nikbakht
Journal: Blood
Blood (2024) 144 (Supplement 1): 3063.
https://doi.org/10.1182/blood-2024-210216
Published: 2024
Journal Articles

Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial

Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Martine Bagot, Youn-H H. Kim, Larisa J Geskin, Pablo L Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Lubomir Sokol, Marie Beylot-Barry, Stéphane Dalle, Eric D. Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S. Khodadoust, Pier Luigi Zinzani, Julien Viotti, David Magrez, Agnes Boyer Chammard, Constance Vagne, Flavien Carraguel, Laura Assante Miranda, Valentine Peri, Sivan Bokobza, Marie-Laure Thibult, Cécile Bonnafous, Florent Carrette, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1609.
https://doi.org/10.1182/blood-2024-200587
Published: 2024
Journal Articles

Results from the First Phase 1 Clinical Study of DR-01, a Non-Fucosylated Anti-CD94 Targeting Antibody in Patients with Relapsed/Refractory Cytotoxic Lymphomas: Dose Escalation and Optimization

Jasmine Zain, Swaminathan P Iyer, Enrica Marchi, Mitul Gandhi, Youn H. Kim, Michael S. Khodadoust, Jonathan E. Brammer, Christina Poh, Pierluigi Porcu, Kimberley Dilley, Matthias Will, Andrea Kantor, Cathrine Leonowens, Nenad Tomasevic, H. Miles Prince, Steven Horwitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 980.
https://doi.org/10.1182/blood-2024-206053
Published: 2024
Journal Articles

Real-World Data Shows Increased Incidence of Autoimmune Disease in Survivors of Childhood Lymphoid Malignancies

Kimberly Ann Davidow, Thomas Z Rohan, Cooper R Roslund, Pierluigi Porcu, Alan S Khoo, Christopher McNair, AnneMarie C Brescia, Jonathan Powell
Journal: Blood
Blood (2024) 144 (Supplement 1): 5094.
https://doi.org/10.1182/blood-2024-194128
Published: 2024
Journal Articles

Suboptimal/Reduced Therapy in Older Patients with T-Cell Lymphoma Resulted in Poorer Outcomes: Report from the International T-Cell Project 1.0

Tetiana Skrypets, Onder Alpdogan, Luana Conte, Monica Civallero, Athina Lymboussaki, Julie M. Vose, Ivan Dlouhy, Maria Elena Cabrera, Felicitas Hitz, Sabela Bobillo, Won Seog Kim, Arnon Nagler, Dario Marino, Ranjana H. Advani, Caterina Stelitano, Pierluigi Porcu, Massimo Federico
Journal: Blood
Blood (2024) 144 (Supplement 1): 6402.
https://doi.org/10.1182/blood-2024-203976
Published: 2024
Journal Articles

Diffuse Large B-Cell Lymphoma and Hepatitis B Virus (HBV) Infection: An Emerging Health Disparity in Philadelphia

Ilana P. Goldberg, Douglas Russ, Roxanna Fouladi, Suraj Nyalakonda, Rebecca Masel, Safiyyah Bhatti, Colin Thomas, Jerald Gong, Thomas R. Klumpp, Alan Khoo, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7728.
https://doi.org/10.1182/blood-2024-206651
Published: 2024
Journal Articles

Clinical Impact of Serum Ferritin Levels and EBV-Positivity in Nodal T-Cell Lymphomas

Suraj Nyalakonda, Madeline Williams, Roxanna Fouladi, Adrian Altieri, Michael Dimino, Quinto John Gesiotto, Rebecca Masel, Safiyyah Bhatti, Onder Alpdogan, Jerald Gong, Alan S Khoo, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6415.
https://doi.org/10.1182/blood-2024-209306
Published: 2024
Journal Articles

Open Label Single Arm Study to Assess the Implementation of Home Based Daratumumab Administration in Patients Being Treated for Multiple Myeloma

Adam F. Binder, Ubaldo Martinez Outschoorn, Carol Gung, Alexandra Cohen, Mallika Saini, Onder Alpdogan, Pierluigi Porcu, Kristin L Rising
Journal: Blood
Blood (2024) 144 (Supplement 1): 7596.
https://doi.org/10.1182/blood-2024-206031
Published: 2024
Journal Articles

Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial

Martine Bagot, Youn H. Kim, Caroline Ram-Wolff, Stéphane Dalle, Neha Mehta-Shah, Auris O Huen, Brian Poligone, Pier Luigi Zinzani, Larisa J Geskin, Anne-Bénédicte Duval-Modeste, Pablo L Ortiz-Romero, Lubomir Sokol, Sherida Woei-A-Jin, Marie Beylot-Barry, Olivier Dereure, Michael S. Khodadoust, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Julien Viotti, Christine Paiva, Agnes Boyer Chammard, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 466.
https://doi.org/10.1182/blood-2024-194796
Published: 2024
Journal Articles

A Two-Part Study Evaluating the Combination of Tazemetostat and CPX-351 (Part 1) and Palbociclib with CPX-351 (Part 2) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Gina Keiffer, Bruno Calabretta, Alexander Mazo, Ubaldo Martinez Outschoorn, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Lindsay Wilde, Margaret Kasner
Journal: Blood
Blood (2023) 142 (Supplement 1): 1550.
https://doi.org/10.1182/blood-2023-186671
Published: 2023
Journal Articles

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

Eric Jacobsen, Dai Maruyama, Pierluigi Porcu, Kensei Tobinai, Pamela B. Allen, Kenji Ishitsuka, Kunihiro Tsukasaki, Shigeru Kusumoto, Francine M. Foss, Nobuhiko Yamauchi, Satoko Morishima, Yoshitaka Imaizumi, Koji Izutsu, Tatyana Feldman, Toyotaka Kawamata, Yasuyuki Kakurai, Hideyuki Yamauchi, Noha Biserna, Ai Inoue, Shinji Tsutsumi, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 303.
https://doi.org/10.1182/blood-2023-172512
Published: 2023
Journal Articles

The Overlap of Skin and Blood T-Cell Clones in Early-Stage Mycosis Fungoides

Daniel Joffe, Lauren Banner, Safiyyah Bhatti, Laura Gleason, Jenna Mandel, Pierluigi Porcu, Neda Nikbakht
Journal: Blood
Blood (2023) 142 (Supplement 1): 4361.
https://doi.org/10.1182/blood-2023-181229
Published: 2023
Journal Articles

Pathobiology and Targeting of CD38 in Cutaneous T-Cell Lymphoma

Colleen Isabelle, Amy Boles, Kathleen McConnell, Robyn Keller, Lara Cheslow, Jonathan Xu, Scott Waldman, Nitin Chakravarti, Pierluigi Porcu, Neda Nikbakht, Anjali Mishra
Journal: Blood
Blood (2023) 142 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2023-189556
Published: 2023
Journal Articles

Increased Incidence of Melanoma, Prostate, Lung, Bladder, Renal and Thyroid Cancer after Diagnosis of Primary Cutaneous B-Cell Lymphoma: A SEER Database Analysis

Lauren Banner, Thomas Z Rohan, Rachel Zachian, Tyler Gross, Daniel Joffe, Pierluigi Porcu, Neda Nikbakht
Journal: Blood
Blood (2023) 142 (Supplement 1): 4409.
https://doi.org/10.1182/blood-2023-182303
Published: 2023
Journal Articles

Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease

Haley L. Klimaszewski, Christoph Weigel, Selamawit Addissie, Sarah Schlotter, Tounkara Fode, James P. Dugan, Bradley M. Haverkos, Lynda Villagomez, Mark Lustberg, Pierluigi Porcu, Timothy Voorhees, Michael A Caligiuri, Christopher C. Oakes, Ginny Bumgardner, Robert Baiocchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4476.
https://doi.org/10.1182/blood-2023-189618
Published: 2023
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

A Phase Ib/II Study Evaluating Navitoclax after Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Gina Keiffer, Sara E. Meyer, Christine Eischen, Ubaldo Martinez Outschoorn, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Lindsay Wilde, Margaret Kasner, Neil Palmisiano
Journal: Blood
Blood (2023) 142 (Supplement 1): 1551.
https://doi.org/10.1182/blood-2023-186765
Published: 2023
Journal Articles

Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Aditi Shastri, Eric J Feldman, Alexander N Starodub, Tatyana Feldman, Cristina P Rodriguez, Zachary D. Epstein-Peterson, Don A. Stevens, Adam J Olszewski, Auris O Huen, Pierluigi Porcu, John C Reneau, Stefan K. Barta, Enrica Marchi, Ahmad H Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Sean Donohue, Joyoti Dey, Sagar Agarwal, Rahul Karnik, Ashwin Gollerkeri, Jared Gollob, Stephen D Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 3081.
https://doi.org/10.1182/blood-2023-181130
Published: 2023
Journal Articles

Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

Nicholas Kendsersky, Rebecca Masel, Amman Bhasin, Tingting Zhan, Carol Gung, Mercy George, Frederick Michael Fellin, Allison Zibelli, Avnish Bhatia, Rajan Singla, Michael Ramirez, Andrew E. Chapman, Patrick Mille, Cassandra Thomas, Joanne Filicko-O'Hara, Barbara Pro, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Andres Ferber, Sameh Gaballa, Ubaldo Martinez Outschoorn
Journal: Blood
Blood (2023) 142 (Supplement 1): 3028.
https://doi.org/10.1182/blood-2023-187847
Published: 2023